NCGI
NVO

Next Century Growth Investors’s Novo Nordisk NVO Stock Holding History

Next Century Growth Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,303
Closed -$1.9M – 138
2024
Q2 		$1.9M Sell
13,303
-16,451
-55% -$2.18M 0.16% 116
2024
Q1 		$3.82M Buy
29,754
+396
+1% +$47.1K 0.33% 87
2023
Q4 		$3.04M Sell
29,358
-3,048
-9% -$301K 0.3% 87
2023
Q3 		$2.95M Sell
32,406
-16,724
-34% -$1.47M 0.32% 78
2023
Q2 		$3.98M Sell
49,130
-11,676
-19% -$954K 0.38% 67
2023
Q1 		$4.84M Sell
60,806
-1,396
-2% -$99K 0.53% 54
2022
Q4 		$4.21M Sell
62,202
-752
-1% -$44.1K 0.51% 54
2022
Q3 		$3.14M Buy
62,954
+542
+0.9% +$29K 0.38% 60
2022
Q2 		$3.48M Buy
+62,412
New +$3.46M 0.45% 60
2013
Q4 		– Sell
-329,070
Closed -$5.57M – 188
2013
Q3 		$5.57M Sell
329,070
-3,310
-1% -$55.7K 0.16% 141
2013
Q2 		$5.15M Buy
+332,380
New +$5.53M 0.17% 128

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Next Century Growth Investors's NVO Position: Q3 2024 in Review

Next Century Growth Investors sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 13,303 shares — an estimated $1.9M sold.

Next Century Growth Investors first reported a position in NVO in Q2 2013 and held it in 11 quarters. The position peaked at $5.57M in Q3 2013. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Next Century Growth Investors reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Next Century Growth Investors sold 13,303 Novo Nordisk shares in Q3 2024, an estimated $1.9M.
  • Next Century Growth Investors first reported a position in Novo Nordisk in Q2 2013 and held it in 11 quarters.
  • Next Century Growth Investors's Novo Nordisk position peaked at $5.57M in Q3 2013.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Next Century Growth Investors's 13F filing for Q3 2024, filed 14 Nov 2024.